Cargando…

Tyrosinemia type III in an asymptomatic girl

Tyrosinemia type 3 (HT3) is a rare inborn error of tyrosine metabolism caused by mutations in the HPD gene encoding 4-hydroxyphenyl-pyruvate dioxygenase, which is transmitted in an autosomal recessive trait. The disorder is characterized by tyrosine accumulation in body fluids and massive excretion...

Descripción completa

Detalles Bibliográficos
Autores principales: Szymanska, Edyta, Sredzinska, Malgorzata, Ciara, Elzbieta, Piekutowska-Abramczuk, Dorota, Ploski, Rafal, Rokicki, Dariusz, Tylki-Szymanska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471395/
https://www.ncbi.nlm.nih.gov/pubmed/28649543
http://dx.doi.org/10.1016/j.ymgmr.2015.10.004
_version_ 1783243941903073280
author Szymanska, Edyta
Sredzinska, Malgorzata
Ciara, Elzbieta
Piekutowska-Abramczuk, Dorota
Ploski, Rafal
Rokicki, Dariusz
Tylki-Szymanska, Anna
author_facet Szymanska, Edyta
Sredzinska, Malgorzata
Ciara, Elzbieta
Piekutowska-Abramczuk, Dorota
Ploski, Rafal
Rokicki, Dariusz
Tylki-Szymanska, Anna
author_sort Szymanska, Edyta
collection PubMed
description Tyrosinemia type 3 (HT3) is a rare inborn error of tyrosine metabolism caused by mutations in the HPD gene encoding 4-hydroxyphenyl-pyruvate dioxygenase, which is transmitted in an autosomal recessive trait. The disorder is characterized by tyrosine accumulation in body fluids and massive excretion of tyrosine derivatives into urine (www.orpha.net). Since it is the least frequent form of tyrosinemia, only few cases with the variable but rather mild clinical features have been described so far. We report an 11 year old girl presenting with no clinical symptoms and with normal mental development who has been diagnosed with HT3 through metabolic screening on the basis of elevated serum level of tyrosine ranging from 425 to 535 μmol/L (normal values: 29–86 μmol/L), and elevated urinary excretion of p-hydroxyphenyl derivatives confirmed genetically with the homozygous c.479A > G (p.Tyr160Cys) missense change in the HPD gene. The girl has been only presenting with recurrent proteinuria of unknown etiology. A phenylalanine- and tyrosine-restricted diet has never been administered. Presented case may suggest that high tyrosine concentration itself does not participate directly in neuronal damage described in patients with tyrosinemia type 3.
format Online
Article
Text
id pubmed-5471395
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54713952017-06-23 Tyrosinemia type III in an asymptomatic girl Szymanska, Edyta Sredzinska, Malgorzata Ciara, Elzbieta Piekutowska-Abramczuk, Dorota Ploski, Rafal Rokicki, Dariusz Tylki-Szymanska, Anna Mol Genet Metab Rep Case Report Tyrosinemia type 3 (HT3) is a rare inborn error of tyrosine metabolism caused by mutations in the HPD gene encoding 4-hydroxyphenyl-pyruvate dioxygenase, which is transmitted in an autosomal recessive trait. The disorder is characterized by tyrosine accumulation in body fluids and massive excretion of tyrosine derivatives into urine (www.orpha.net). Since it is the least frequent form of tyrosinemia, only few cases with the variable but rather mild clinical features have been described so far. We report an 11 year old girl presenting with no clinical symptoms and with normal mental development who has been diagnosed with HT3 through metabolic screening on the basis of elevated serum level of tyrosine ranging from 425 to 535 μmol/L (normal values: 29–86 μmol/L), and elevated urinary excretion of p-hydroxyphenyl derivatives confirmed genetically with the homozygous c.479A > G (p.Tyr160Cys) missense change in the HPD gene. The girl has been only presenting with recurrent proteinuria of unknown etiology. A phenylalanine- and tyrosine-restricted diet has never been administered. Presented case may suggest that high tyrosine concentration itself does not participate directly in neuronal damage described in patients with tyrosinemia type 3. Elsevier 2015-10-22 /pmc/articles/PMC5471395/ /pubmed/28649543 http://dx.doi.org/10.1016/j.ymgmr.2015.10.004 Text en © 2015 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Szymanska, Edyta
Sredzinska, Malgorzata
Ciara, Elzbieta
Piekutowska-Abramczuk, Dorota
Ploski, Rafal
Rokicki, Dariusz
Tylki-Szymanska, Anna
Tyrosinemia type III in an asymptomatic girl
title Tyrosinemia type III in an asymptomatic girl
title_full Tyrosinemia type III in an asymptomatic girl
title_fullStr Tyrosinemia type III in an asymptomatic girl
title_full_unstemmed Tyrosinemia type III in an asymptomatic girl
title_short Tyrosinemia type III in an asymptomatic girl
title_sort tyrosinemia type iii in an asymptomatic girl
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471395/
https://www.ncbi.nlm.nih.gov/pubmed/28649543
http://dx.doi.org/10.1016/j.ymgmr.2015.10.004
work_keys_str_mv AT szymanskaedyta tyrosinemiatypeiiiinanasymptomaticgirl
AT sredzinskamalgorzata tyrosinemiatypeiiiinanasymptomaticgirl
AT ciaraelzbieta tyrosinemiatypeiiiinanasymptomaticgirl
AT piekutowskaabramczukdorota tyrosinemiatypeiiiinanasymptomaticgirl
AT ploskirafal tyrosinemiatypeiiiinanasymptomaticgirl
AT rokickidariusz tyrosinemiatypeiiiinanasymptomaticgirl
AT tylkiszymanskaanna tyrosinemiatypeiiiinanasymptomaticgirl